Kauris-CTS 375 Injection
Marketer
Kauris Care Private Limited
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Kauris-CTS 375 Injection
Combiflox-375 Injection is a multi-component medication used to combat diverse bacterial infections. Its action inhibits microbial proliferation, thereby curbing infection spread. Administration must be overseen by a qualified medical practitioner. Strictly adhere to the prescribed dosage schedule; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately to your physician. Seek immediate medical attention for allergic reactions (e.g., skin rashes, pruritus, edema, dyspnea). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are vital for optimal recovery. Your doctor might order blood tests and other diagnostics to monitor treatment response.
Uses of Kauris-CTS 375 Injection
Infections caused by bacteria
Major Benefits of Kauris-CTS 375 Injection:
This medication will be administered by your physician or their qualified assistant; please refrain from self-medicating.
Common Side effects of Kauris-CTS 375 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Kauris-CTS 375 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kauris-CTS 375 Injection works:
Ceftriaxone and Sulbactam, combined as Kauris-CTS 375 Injection, offer targeted antibacterial action. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Kauris-CTS 375 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Kauris-CTS 375 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Kauris-CTS 375 Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Kauris-CTS 375 Injection might reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Kauris-CTS 375 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Kauris-CTS 375 Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Kauris-CTS 375 Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Kauris-CTS 375 Injection :
Omit Kauris-CTS 375 Injection doses only after physician consultation.
Facts to Know About Kauris-CTS 375 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently